214 related articles for article (PubMed ID: 340942)
21. [Antiplatelet drugs (author's transl)].
Dechavanne M; Follea G; Trzeciak MC
Anesth Analg (Paris); 1979; 36(7-8):283-7. PubMed ID: 525834
[TBL] [Abstract][Full Text] [Related]
22. New job for an old drug?
Relman AS
N Engl J Med; 1978 Feb; 298(6):333-4. PubMed ID: 622092
[No Abstract] [Full Text] [Related]
23. Reduction in the severity of myocardial infarction by sulfinpyrazone.
Innes IR; Weisman H
Am Heart J; 1981 Aug; 102(2):153-7. PubMed ID: 7258086
[TBL] [Abstract][Full Text] [Related]
24. Anturane reinfarction trial.
Evans DW
Lancet; 1978 Aug; 2(8085):366-7. PubMed ID: 79725
[No Abstract] [Full Text] [Related]
25. In vivo platelet hyperactivity and factor VIII related antigen increase long after myocardial infarction. A controlled effect of sulfinpyrazone.
Cortellaro M; Boschetti C; Beggi P; Polli EE
Scand J Haematol; 1981 Feb; 26(2):106-14. PubMed ID: 6454960
[TBL] [Abstract][Full Text] [Related]
26. Anturane reinfarction trial.
Meier P
N Engl J Med; 1981 Mar; 304(12):730. PubMed ID: 7464868
[No Abstract] [Full Text] [Related]
27. A serial study of platelet reactivity throughout the first six months after myocardial infarction: its modification by sulphinpyrazone.
Kubik MM; Richardson SG
Postgrad Med J; 1987 May; 63(739):351-6. PubMed ID: 3118351
[TBL] [Abstract][Full Text] [Related]
28. Drug trials in myocardial infarction. Lessons to be learned from the Anturane Reinfarction Trial.
Sherry S
Eur J Clin Pharmacol; 1980 Jun; 17(6):401-7. PubMed ID: 7398732
[TBL] [Abstract][Full Text] [Related]
29. The Anturane Reinfarction Trial: reevaluation of outcome.
N Engl J Med; 1982 Apr; 306(16):1005-8. PubMed ID: 7038496
[No Abstract] [Full Text] [Related]
30. Preventing death after myocardial infarction.
Horwitz DL
Compr Ther; 1980 Jun; 6(6):3-4. PubMed ID: 7379491
[No Abstract] [Full Text] [Related]
31. [Timolol reduces mortality and reinfarct in patients surviving an acute myocardial infarct. The Norwegian Multicenter Study Group].
MMW Munch Med Wochenschr; 1981 May; 123(22):929-38. PubMed ID: 6787417
[TBL] [Abstract][Full Text] [Related]
32. FDA says no to anturane.
Kolata GB
Science; 1980 Jun; 208(4448):1130-2. PubMed ID: 6990491
[No Abstract] [Full Text] [Related]
33. Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
Castaldi PA
Aust N Z J Med; 1981 Dec; 11(6):673-7. PubMed ID: 7036973
[TBL] [Abstract][Full Text] [Related]
34. Cardiac death prevention in post-myocardial infarction patients: a review.
Boissel JP; Leizorovicz A; Faucomprez C
Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
[No Abstract] [Full Text] [Related]
35. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study.
Lewis HD; Davis JW; Archibald DG; Steinke WE; Smitherman TC; Doherty JE; Schnaper HW; LeWinter MM; Linares E; Pouget JM; Sabharwal SC; Chesler E; DeMots H
N Engl J Med; 1983 Aug; 309(7):396-403. PubMed ID: 6135989
[TBL] [Abstract][Full Text] [Related]
36. Sulfinpyrazone: a review of its pharmacological properties and therapeutic use.
Margulies EH; White AM; Sherry S
Drugs; 1980 Sep; 20(3):179-97. PubMed ID: 7000488
[TBL] [Abstract][Full Text] [Related]
37. Sulfinpyrazone after myocardial infarction?
Beilin LJ
Med J Aust; 1978 Aug; 2(5):186-8. PubMed ID: 364265
[No Abstract] [Full Text] [Related]
38. [Sulfinpyrazone in the prevention of sudden cardiac death after myocardial infarct].
Foz M
Med Clin (Barc); 1980 Jun; 75(1):32-4. PubMed ID: 7392709
[No Abstract] [Full Text] [Related]
39. [The Anturan reinfarct study].
Sherry S
Wien Med Wochenschr Suppl; 1980; 61():17-22. PubMed ID: 6930766
[No Abstract] [Full Text] [Related]
40. Secondary prevention of myocardial infarction--the present state of the ART.
Mitchell JR
Br Med J; 1980 May; 280(6223):1128-30. PubMed ID: 7000236
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
